Exploratory Study on the Efficacy and Safety of Sintilimab Combined With Lenvatinib and HAIC for Neoadjuvant Therapy of Borderline Resectable Hepatocellular Carcinoma
Latest Information Update: 04 Apr 2025
At a glance
- Drugs Fluorouracil (Primary) ; Folinic acid (Primary) ; Lenvatinib (Primary) ; Oxaliplatin (Primary) ; Sintilimab (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 04 Apr 2025 New trial record